We investigate how direct-to-consumer advertising of smoking cessation products is affected by Food and Drug Administration regulations. Because of their effectiveness, these products could be the key to meeting public health goals to reduce smoking. Our study period covers the evolution of the market as products are introduced while some of the older products move from prescription to over-the-counter (OTC) status. The movement to OTC substantially reduces disclosure requirements and reduces costs to advertise. Our results show that OTC status increases the amount firms spend on advertising and increases the number and pages of magazine advertisements. Copyright Springer Science+Business Media, LLC 2007
Download Info
To download:
If you experience problems downloading a file, check if you have the
proper application to
view it first. Information about this may be contained
in the File-Format links below. In case of further problems read
the IDEAS help
page. Note that these files are not on the IDEAS
site. Please be patient as the files may be large.
As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.
Volume (Year): 31 (2007) Issue (Month): 2 (April) Pages: 185-208 Download reference. The following formats are available: HTML
(with abstract),
plain text
(with abstract),
BibTeX,
RIS (EndNote, RefMan, ProCite),
ReDIF
References listed on IDEAS Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
Jones, Andrew M., 2000.
"Health econometrics,"
Handbook of Health Economics,
in: A. J. Culyer & J. P. Newhouse (ed.), Handbook of Health Economics, edition 1, volume 1, chapter 6, pages 265-344
Elsevier.
[Downloadable!] (restricted)
Chaloupka, Frank J. & Warner, Kenneth E., 2000.
"The economics of smoking,"
Handbook of Health Economics,
in: A. J. Culyer & J. P. Newhouse (ed.), Handbook of Health Economics, edition 1, volume 1, chapter 29, pages 1539-1627
Elsevier.
[Downloadable!] (restricted)
Other versions:
Meredith B. Rosenthal & Ernst R. Berndt & Julie M. Donohue & Arnold M. Epstein & Richard G. Frank, 2003.
"Demand Effects of Recent Changes in Prescription Drug Promotion,"
NBER Chapters,
in: Frontiers in Health Policy Research, Volume 6, pages 1-26
National Bureau of Economic Research, Inc.
[Downloadable!]
Bulow, J. & Klemperer, P., 1999.
"The Tobacco Deal,"
Economics Papers
1999-w11, Economics Group, Nuffield College, University of Oxford.
Other versions:
Cited by: (explanations, Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.)